Core Viewpoint - Consumer staple companies may benefit from higher inflation due to their ability to pass on cost increases to customers, but consumer resistance to price hikes is a concern [2]. Group 1: PepsiCo - PepsiCo's second-quarter revenue increased by 2%, driven entirely by higher prices, which contributed 4 percentage points, while lower volume subtracted about 1.5 percentage points [5]. - Adjusted operating income for PepsiCo fell by 3%, indicating that price hikes were insufficient to offset rising costs [5]. - PepsiCo's share price dropped by 16.9% over the past year, contrasting with a 16.8% gain in the S&P 500 index during the same period [6]. - The price-to-earnings (P/E) ratio for PepsiCo increased from 19 to 26, which is still lower than the S&P 500's P/E of 30, suggesting potential for patient investors [7]. Group 2: Procter & Gamble - Procter & Gamble's fiscal third-quarter adjusted sales grew by only 1%, with higher prices accounting for the entire increase and volumes remaining flat [9]. - In the fourth quarter, adjusted sales increased by 2%, with higher prices and mix each contributing 1 percentage point, while volume remained constant [10]. - Procter & Gamble's stock price decreased by 7.9% over the past year, and its P/E multiple contracted from 28 to less than 25 [10].

Core Points - Bon Natural Life Limited has received notification from Nasdaq regarding non-compliance with the Minimum Bid Price Requirement due to its Class A ordinary shares closing bid price being below $1.00 for 30 consecutive business days [1] - The company's securities have also closed at $0.10 or less for the last ten consecutive trading days, leading to additional grounds for potential delisting [1] - An additional Notification Letter indicated that Nasdaq has determined to delist the company's securities based on public interest concerns related to its March 2025 best efforts offering [2] - The company has filed an appeal and requested a hearing before a Nasdaq Listing Qualifications Panel, which will stay the delisting pending the Panel's decision [3] - The company is evaluating options to regain compliance with Nasdaq Listing Rules, but there are no guarantees of success in this process [3] Company Overview - Bon Natural Life Limited is a Cayman Islands company engaged in the natural, health, and personal care industries [4]